Enzymatic Protoplast Isolation Platform for Transgene-Free Genome Editing in Blueberry (Vaccinium)

Transgene-Free Protoplast Platform for Accelerated Blueberry Breeding

This protoplast isolation technology employs a targeted enzymatic treatment to remove the cell wall from blueberry (Vaccinium) cells, enabling direct access to the cellular membrane for precise genetic and molecular manipulation. Precision agriculture and modern fruit breeding increasingly rely on tools such as genome editing, transient expression, and cellular localization assays to validate traits and accelerate cultivar development. The blueberry industry represents a significant and growing agricultural market, contributing approximately $9.1 billion in annual economic impact to the U.S. economy. As demand increases for high-quality, sustainably produced, and non-GMO fruit, breeders and biotechnology developers require tools that accelerate innovation without triggering GMO labeling or regulatory barriers. However, woody perennial crops like blueberries have long generation times and are difficult to transform and regenerate using traditional approaches. Additionally, conventional transgenic methods often require stable integration of foreign DNA, triggering GMO regulatory requirements and limiting consumer acceptance.

Researchers at the University of Florida have developed an enzymatic protoplast platform designed for research, breeding, and pre-commercial development applications in the blueberry sector. Using a defined enzyme combination enables direct DNA or RNA delivery for transient assays and transgene-free genome editing while maintaining cell viability. By enabling faster trait validation and transgene-free genome editing, this platform shortens breeding timelines while aligning with consumer expectations for non-GMO food products, making it a valuable tool for next-generation blueberry improvement.

Application

This enzymatic protoplast platform enables transgene-free genome editing, gene validation, and rapid trait development in blueberries (Vaccinium) to accelerate breeding of improved, non-GMO food crops

Advantages

• Supports precise transgene-free genome editing to develop improved blueberry traits development while maintaining non-GMO status, meeting consumer and regulatory expectations
• Shortens breeding timelines by enabling rapid trait and gene-function validation subsequently reducing the time required to introduce desirable traits, enabling quicker development of improved cultivars
• Provides a rapid protoplast-based workflow that streamlines genome editing, reagent testing and other molecular tools, allowing faster evaluation and introduction of desirable traits

Technology

This technology provides an enzymatic protoplast isolation platform that uses a defined combination of cell wall-digesting enzymes to separate blueberry (Vaccinium) cells and generate viable, wall-free protoplasts. Removal of the cell wall allows direct delivery of DNA or RNA into the cytosol, supporting applications such as transient gene expression, cellular localization studies, genome editing reagent testing, and protoplast fusion. Since edits can be introduced without stable integration of foreign transgenes, the resulting plants can be developed as non-GMO products while still benefiting from the precise genome modifications. The system is compatible with multiple blueberry tissue types and is designed for use by breeders and researchers to accelerate trait validation, advance climate-adapted and disease-resistant varieties, and support high-throughput screening of candidates prior to conventional breeding and commercialization.